Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy

Stephen Heitner, Katherine L. Fischer

    Research output: Contribution to journalReview article

    Abstract

    Hypertrophic cardiomyopathy is a heterogenous condition associated with a myriad of symptoms. Just as in other disease states, the aim of medical therapy is the alleviation of suffering, improvement of longevity, and the prevention of complications. This article focuses on the associated comorbidities seen in patients with hypertrophic cardiomyopathy, potential lifestyle interventions, and conventional medical treatments for symptomatic hypertrophic cardiomyopathy.

    LanguageEnglish (US)
    Pages45-54
    Number of pages10
    JournalCardiology Clinics
    Volume37
    Issue number1
    DOIs
    StatePublished - Feb 1 2019

    Fingerprint

    Hypertrophic Cardiomyopathy
    Life Style
    Psychological Stress
    Comorbidity
    Therapeutics

    Keywords

    • Beta-blocker
    • Calcium channel blocker
    • Cardiomyopathy
    • Disopyramide
    • Hypertrophic
    • Lifestyle
    • Obstruction
    • Ranolizine

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Cite this

    Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy. / Heitner, Stephen; Fischer, Katherine L.

    In: Cardiology Clinics, Vol. 37, No. 1, 01.02.2019, p. 45-54.

    Research output: Contribution to journalReview article

    @article{50845e9698f2432db5fb48759de53eab,
    title = "Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy",
    abstract = "Hypertrophic cardiomyopathy is a heterogenous condition associated with a myriad of symptoms. Just as in other disease states, the aim of medical therapy is the alleviation of suffering, improvement of longevity, and the prevention of complications. This article focuses on the associated comorbidities seen in patients with hypertrophic cardiomyopathy, potential lifestyle interventions, and conventional medical treatments for symptomatic hypertrophic cardiomyopathy.",
    keywords = "Beta-blocker, Calcium channel blocker, Cardiomyopathy, Disopyramide, Hypertrophic, Lifestyle, Obstruction, Ranolizine",
    author = "Stephen Heitner and Fischer, {Katherine L.}",
    year = "2019",
    month = "2",
    day = "1",
    doi = "10.1016/j.ccl.2018.08.004",
    language = "English (US)",
    volume = "37",
    pages = "45--54",
    journal = "Cardiology Clinics",
    issn = "0733-8651",
    publisher = "W.B. Saunders Ltd",
    number = "1",

    }

    TY - JOUR

    T1 - Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy

    AU - Heitner, Stephen

    AU - Fischer, Katherine L.

    PY - 2019/2/1

    Y1 - 2019/2/1

    N2 - Hypertrophic cardiomyopathy is a heterogenous condition associated with a myriad of symptoms. Just as in other disease states, the aim of medical therapy is the alleviation of suffering, improvement of longevity, and the prevention of complications. This article focuses on the associated comorbidities seen in patients with hypertrophic cardiomyopathy, potential lifestyle interventions, and conventional medical treatments for symptomatic hypertrophic cardiomyopathy.

    AB - Hypertrophic cardiomyopathy is a heterogenous condition associated with a myriad of symptoms. Just as in other disease states, the aim of medical therapy is the alleviation of suffering, improvement of longevity, and the prevention of complications. This article focuses on the associated comorbidities seen in patients with hypertrophic cardiomyopathy, potential lifestyle interventions, and conventional medical treatments for symptomatic hypertrophic cardiomyopathy.

    KW - Beta-blocker

    KW - Calcium channel blocker

    KW - Cardiomyopathy

    KW - Disopyramide

    KW - Hypertrophic

    KW - Lifestyle

    KW - Obstruction

    KW - Ranolizine

    UR - http://www.scopus.com/inward/record.url?scp=85055529008&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85055529008&partnerID=8YFLogxK

    U2 - 10.1016/j.ccl.2018.08.004

    DO - 10.1016/j.ccl.2018.08.004

    M3 - Review article

    VL - 37

    SP - 45

    EP - 54

    JO - Cardiology Clinics

    T2 - Cardiology Clinics

    JF - Cardiology Clinics

    SN - 0733-8651

    IS - 1

    ER -